Radiomic Signature as Predictive Marker of Response to Chemoradiation and Durvalumab in Stage III NSCLC.
Clinical trial NCT04364776 · UNKNOWN
Trial details
- NCT number
- NCT04364776
- Sponsor
- Fondazione IRCCS Policlinico San Matteo di Pavia
- Status
- UNKNOWN
- Study type
- OBSERVATIONAL
- Start date
- 2020-01-15
- Primary completion
- 2023-12-15
- Enrollment
- 100
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.